Table 1.
N % | RR (95% CI )* | P‐value | ||
Age | >10 | 56 | 1 | 0,328 |
<10 | 9 | 0,38 (0,05‐2,5) | ||
Gender | F | 48 | 1 | 0,188 |
M | 16 | 0,4 (0,1‐1,5) | ||
Size | >2cm | 57 | 1 | 0,372 |
<2cm | 8 | 0,63(0,23‐1,73) | ||
Lymph node metastasis | Y | 40 | 1 | 0,014 |
N | 25 | 0,34 (0,14‐0,8) | ||
Multicentricity | Y | 17 | 1 | 0,719 |
N | 48 | 1,17 (0,48‐2,84) | ||
Distant Metastasis | Y | 19 | 1 | 0,014 |
N | 46 | 0,15 (0,02‐0,96) | ||
Post therapy scan uptake | TB | 45 | 1 | 0,353 |
OTB | 20 | 0,52 (0,17‐1,60) |
RR – risk relative; 95% CI – 95 confidence interval, Y‐ yes (present at diagnosis), N‐ No (absent at diagnosis; TB‐ Thyroid bed; OTB‐outside thyroid bed